Chronic HH exposure caused reproducible change in social interaction as well as anxiety-like behaviors
HH exposure exhibits detrimental effects on body weight at 3HH (p<0.01), 7HH (p<0.05) as well on food intake at 3HH (p<0.05) and 7HH (p<0..01) as compare to control Supplementary Fig. 2.
Previous studies have shown vulnerability in hippocampal-dependent tasks, so we sought to examine whether hippocampal based social memory is affected. The behavioral schematic setup was representing two trials, each consisting of 10 min (Fig. 1a). Representative track-plots are provided for both trial 1 and trial 2 from control and 7 days HH exposed rats showings differential movement in the chamber (Fig. 1 b). Statistical analysis showed that time spent in the chamber containing social stimuli were markedly lower in 7HH exposed (F1,18 = 7.764, p<0.01) animals. In contrast, this time was significantly higher with empty enclosure (p<0.05) as compared to control rats (two-way ANOVA, Bonferroni’s multiple comparison test, Fig. 1 c, n=10). However, contact behaviour that represents the direct exploration of two stimuli, was also altered in 7HH exposed rats as there was a decrease in contact behavior with social stimuli (F1,18 = 7.709, p<0.05) and it increases when rats explored with an empty enclosure. Quantification of Trial 2 parameters revealed that both stressed (7HH) and control animals spent almost similar time in the chamber with the novel stimuli, but 7HH stressed animals spend more time with the familiar animal compared to control (F1,18 = 6.225, p<0.05, Fig. 1 d). However, the direct contact behaviour of test rats from 7HH group was lower (F1,18 = 12.51, p<0.05) with novel stimuli and higher with familiar (p<0.05).
During many psychiatric disease states, anxiety and social deficits are co-expressed as the baso-lateral amygdala and the ventral hippocampus are reported to share conventional circuitry and robust reciprocal connections. In line with this information we next evaluated anxiety-like behaviour using EPM. Representative track plot shown for reference as lesser track movement of rats recorded in open arm (Fig.1 e). Exposure to 7HH reduced the time spent in open arm significantly (one-way ANOVA, F 3, 36 = 11.35, p<0.01, Fig.1 f, Tukey’s post-hoc test, n=10) as compared to CC but no significant reduction observed at 1HH and 3HH exposure.
Together, these experiments suggest 7 days of HH exposure diminished social interaction behaviour in rats by reducing the discrimination between social stimuli as the hippocampus being one of the affected brain regions. Along with social interaction, anxiety-like behaviour was also up-surged after 7HH exposure.
HH exposure diminishes expression of BDNF, Serotonin and pCREB in DG
Given that BDNF and Serotonin has been demonstrated to regulate mood associated behavior in rat, we investigated the effect of HH exposure on their expression. We found that the expression levels of BDNF decreased significantly in temporal manner straight from 1HH (one-way ANOVA, F 3, 20 = 9.108, p<0.01, Tukey’s post-hoc test, Fig. 2 a, b, n=3), 3HH (p<0.01) and 7HH (p<0.01) exposure in DG indicated by representative IHC images as well. We also found decrease in mRNA levels of BDNF as well Fig 3 A, Fig 3 B. Consistent with this observation also we found decrease in BrdU+ BDNF+ cells (Unpaired t-test, F 5, 5 = 2.336, p<0.01, n=3) in DG as compare to control after 7HH exposure indicated deficits in adult neurogenesis (Fig.2 c, d). Simultaneously we also observed striking difference in the expression of Serotonin (5HT) in the DG (Unpaired t-test, F 5, 5 = 1.374, p<0.01, n=6, Fig.2 e) as well its levels in the hippocampus measured by HPLC (Unpaired t-test, F 5, 5 = 2.351, p<0.01, n=6, Fig.2 f). Furthermore, we found that HH exposure for 3 days (one-way ANOVA, F 3, 20 = 13.39, p<0.05, Tukey’s post-hoc test, Fig. 2 g, h, n=3) and 7 Days (p<0.001) significantly reduced the pCREB positive nuclei in the DG region. mRNA expression of Creb1 also decreased after 1HH, 3HH and 7HH exposure in hippocampus Fig 3 B.
Overall, these results suggest that HH exposure upsets the microenvironment of the DG by altering the levels of BDNF, Serotonin and pCREB in day dependent manner that might associated with deficits in social and elevation of anxiety like behavior.
HH exposure proved to be detrimental for neurogenesis in adult rat brain
We next investigated the effect of stressful HH exposure on the proliferation and maturation of adult neuronal cells in the DG as BDNF, Serotonin and pCREB are very well-established influencers of adult neurogenesis that too regulate associated behaviors like social interaction and anxiety. Using RT2 profiler array of neurogenesis, we explore the mRNA expression of different functional classes of genes. Fold value that was more than 2 was considered for statistically significance. There was generalized down-regulation of different functional classes like Cell adhesion molecule, cell cycle, apoptosis, cell differentiation, cytokines, growth factors, neuronal migration, signal transduction, synaptic function, synaptogenesis and axogenesis, transcription factors and co-factors, that regulate adult neurogenesis such as related molecules in mRNA levels after 1HH (viz. Adora1, Alk, Bdnf, Bmp2, Bmp4, Cdk5r1, Cdk5rap2, Chat, Creb 1, Dcx, Dlg4, Dll1, Dvl3, Drd2, Egf, Fgf2, Gdnf, Grin1, Hey1, Hey2, Map2, Mdk, Neurod1, Neurog1, Notch1, Notch2, Nrg1, Nrp1,Pax2, S100b, Sox2, Sox8). 3HH exposure also decreased adult neurogenesis related molecules mRNA levels (viz. Adora1, Adora2a, Apbb1, Apoe, App, Bdnf, Bmp2, Bmp4, Cdk5r1, Cdk5rap2, Creb 1, Dcx, Dlg4, Dll1, Drd2, Dvl3, Ep300, Egf, Fgf2, Grin1, Hey1, Hey2, Map2, Mdk, Mef2c, Ndn, Neurod1, Notch1, Notch2, Nrg1, Nrp1, Olig2, S100a6, Sod1, Sox2, Sox8). mRNA expression of adult neurogenesis also showed declined expression (viz. Adora1, Adora2a, Apbb1, Apoe, App, Bdnf, Bmp2, Bmp4, Cdk5r1, Cdk5rap2, Creb 1, Dcx, Dlg4, Dll1, Drd2, Dvl3, Ep300, Egf, Fgf2, Gdnf, Grin1, Hey1, Hey2, Map2, Mdk, Mef2c, Ndn, Neurod1, Notch1, Notch2, Nrg1, Nrp1, Olig2, S100a6, Sod1, Sox2, Sox8) (Fig. 3A and Fig. 3B, n=3).
Representative immunofluorescence images are shown in Fig. 4a, represents a marked reduction in BrdU positive (+ve) cells after time-dependent HH exposure, which is significantly reduced at 7 days of exposure (one-way ANOVA, F 3, 20 = 6.928, p<0.01, Tukey’s post-hoc test, Fig. 4b, n=6). Endogenous neuronal proliferation marker Ki-67, showed marked reduction at 7 HH exposure (F 3, 20 = 4.033, p<0.05, Fig. 4 a and b). The idea of designing this experiment is to know the change in the phenotypic expression of Neuronal Proliferation cells (NPCs), labeled with BrdU, that can differentiate into astrocyte (GFAP) and neurons (SOX2, NeuN). No. of NPCs labeled with BrdU+SOX2+ is significantly depleted upon 7HH exposure (unpaired t-test, F 5, 5 =4.616, p<0.01, Fig. 4 c and d, n=3), indicating deficits in neurogenesis. Whereas no significant difference was found in NPCs (BrdU+ GFAP+), indicating no alteration in gliogenesis (Fig. 4 c and d). 7HH exposure markedly reduced the BrdU+ DCX+ cells (F 5, 5 =3.534, p<0.01) and DCX+ NeuN+ cells (F 5, 5 =4.034, p<0.001), indicating a decrease in overall surviving neurons in DG (Fig. 4 e). There was no significant difference observed for BrdU+ NeuN+ cells as well as the mean intensity of NeuN (mature neuronal population) data not shown here. Immuno-micrographs describe the sub-population of immature neuronal marker DCX positive cells at the proliferative stage, Intermediate stage, and post-mitotic stage in DG (Fig. 4 f). Dramatic reduction in DCX cells at proliferative stage (one-way ANOVA, F 3, 20 = 17.56, p<0.001, Tuckey’s post-hoc test), Intermediate stage (F 3, 20 = 14.50, p<0.001), and at post-mitotic stage (F 3, 20 = 8.813, p<0.01, Fig. 4 g) cells straight after 1HH exposure. This reduction continued at 3HH (p<0.001) (p<0.001), (p<0.01) and at 7HH (p<0.0001), (p<0.0001), (p<0.01) Fig. 4 h, I and j respectively. We also observed significant decrease in the mRNA expression of DCX at 1HH, 3HH and 7HH exposure as compare to control Fig 3 a, Fig 3 b. No significant difference was observed in NeuN mean intensity supplementary Fig 3.
We inferred this results as 7HH exposure procreate deficits in generation of NPCs, immature neurons as well maturation of neurons whereas no change was observed in mature population of neurons and in gliogenesis. The observed deficits in neurogenesis are supported by mRNA expression of genes that contribute to different functional class associated with neurogenesis.
HH evokes NLRP3 Inflammasome mediated neuroinflammation and microglial activation
To assess the expression of inflammatory cytokine and their receptors we used RT2 profiler for inflammatory cytokines and receptors. Quantitative PCR array analysis revealed modulation of mRNA expression. mRNA expression of pro-inflammatory genes like CXCL1, CXCL12, CXCR2, IFNG, VEGFA, CSF3, IL1B, CCR1, CCR8, CCR5, IL10RA, LTB which related to decrease in neurogenesis and microglial activation were shown to be upregulated. On the other hand mRNA expression of genes like IL1A, IL1RN, BMP2, CD40LG that are anti-inflammatory and positively regulate neurogenesis are decreased after HH exposure. We previously reported that temporal exposure of HH activates microglia and astrocytes in the DG followed by up-regulation of pro-inflammatory cytokines right from 1 day of exposure. Fold value that was more than 2 was considered for statistically significance (Fig 5, n=3).
Induction of pro-inflammatory cytokine lead us to further investigate the role of other neuro-inflammation associated mechanisms that may contribute to such pathophysiology we explored the expression of NLRP3/NFkB pathway. Here, we observed inflation in the phosphorylation in NFkB at its subunit 536 in hippocampus after 3HH (one-way ANOVA, F 3, 12 = 7.436, p<0.05, Tuckey’s post-hoc, test n=3, Fig 6 a, b, c) and 7HH (p<0.05) exposure. We found a striking upsurge in the expression of levels of IL1β immediately after 1day (one-way ANOVA, F 3, 16 = 16.85, p<0.01, n=3, Fig 6 a, b, c), 3day (p<0.01) and continued till 7day (p<0.001) in the hippocampus. We also found increase in the mRNA levels of IL1β shown in the RT-PCR panel ( Fig 5). In consistence with that we also observed significant increase in the NLRP3 expression in the DG after 1HH (one-way ANOVA, F 3, 20= 12.15, p<0.05, n=3, Fig 6 a, b, c), 3HH (p<0.001) and 7HH (p<0.001) exposure compare to control. We next evaluate the levels of downstream molecule that is caspase-1 and it also showed up regulation of the expression after 3HH (one-way ANOVA, F 3, 12 = 9.246, p<0.05, n=3, Fig 6 a,c) and 7HH(p<0.01). To access the activated microglia stained with CD-68 we co-label them and we found elevation in the number of Iba+CD-68+ cells in the DG after 3HH exposure (one-way ANOVA, F 5, 5 = 3.266, p<0.05, n=3, Fig 6 d,e) as compare to control (CC) group.
Overall, theses results indicate elevation in the NLRP3 signalling indicated by induction in expression of IL1β, Caspase-1 as well NLRP3 expression in the DG. Simultaneously phosphorylation of NFkB and microglial activation observed which indicate elevation of neuro-inflammation in hippocampus. mRNA expression up-regulation of proinflammatory cytokines and their receptor right from day 1 strengthen these observations.
Differential expression of E-type prostanoid receptors after time-dependent HH exposure
We earlier observed induction in the PGE2 conc. And associated neuroinflammation in the hippocampus and plasma, but its active downstream receptor was not explored during HH. We next checked the expression of all PGE2 receptor expression in hippocampus. Representative immunoblot of EP1 receptor and its quantitative analysis revealed its marked increase at 3HH (one-way ANOVA, F 3, 12 = 4.693, p<0.05, Fig. 7 a) p<0.05) and at 7HH exposure (p<0.05). Expression of another prostanoid receptor EP2 was (one-way ANOVA, F 3, 12 = 3.887, p<0.05, Fig 7 b) up-regulated after 7 day of HH exposure as indicated by representative immunoblot. Whereas, no significant difference was found in the expression of EP3, and EP4 receptors in the hippocampal tissue lysate after time-dependent exposure to HH represented with immunoblots and quantitative analysis (Fig 7 c and d).
These data indicate that HH differentially regulate expression of PGE2 G-protein coupled EP receptors. Only EP1 and EP2 receptors were reproducibly up-regulated after 3 and 7 days of HH exposure respectively, whereas expression EP3 and EP4 receptors were unaltered in the hippocampus after HH exposure at any day.
PGE2 receptor EP1 is evident in the activated microglia as well as in astrocyte during HH exposure.
Induction in the EP1 expression in hippocampus lead us to examine its expression in the cell types in DG. Microglia and astrocyte activation was also prominent in the DG during HH exposure which opens the possibility of EP1R expression in these cell types. So we next performed a co-labelling experiment and found a significant increase in the CD-68+ EP1R+ (yellow) cells in the DG after 3HH exposure (Unpaired t-test, F 5, 5 = 1.202, p<0.01, Fig. 8 a, b) in the DG. Similarly, we found an interesting observation where EP1R+ GFAP+ (yellow) cells were significantly more in DG after 3 days of HH (Unpaired t-test, F 5, 5 =2.806, p<0.001, Fig. 8 c, d) exposure as compare to control.
Taken, together we can say EP1R expression in the DG contributing to the activation of glial cells and influencing neurogenic niche during HH exposure.
COX-1 dependent PGE2 response via downstream EP1 receptor is critical for the induction of social interaction deficits during HH exposure.
There are COX-1 and EP1 deficiency reported to abolished social avoidance and impulsive behavior under acute social and environmental stress. We found significant increase in protein expression of EP1R in hippocampus after 7HH exposure. The Tukey’s post-hoc test revealed the considerable increase in EP1R expression after 7HH and was markedly decreased after treatment with valeryl salicyclate (ValS), COX-1 inhibitor (F 3, 12 = 8.444, p<0.05, Fig. 9 a) and SC19220, EP1R antagonist (p<0.01). We previously reported increase in COX-1 expression during 1HH, 3HH and 7HH of exposure. Significant positive correlation in the expression of COX-1 and EP1 was observed (Pearson correlation, r = 0.6722, p<0.01, Fig. 9 b). This striking result lead us to further carried out social interaction test in order to understand how pharmacological inhibition of COX-1 and EP1 receptor during HH affect social behaviour. Exposure of rats to HH for 7days (p<0.001) significantly reduced the time spent with social stimuli. Treatment withValS (Two-way ANOVA, F 3, 40 = 8.778, p<0.05) and SC19220 (p<0.01, Fig. 9 c) during 7HH increased time spent with social stimuli. It is clearly indicated in (Fig. 9 d) thatdirect contact of test rat with social stimuli was significantly elevated after treatment with ValS (F 3, 40 = 4.679, p<0.05) and SC19220 (p<0.05), which was reduced in 7HH (p<0.05) exposed rats. During Trial 2, 7HH exposure decrease time spent with novel animal and both treatments showed increased time spent with novel animal although this difference was not significant.7HH group animals spent significantly higher time with familiar rat (Two–way ANOVA, F 3, 40 = 6.664, p<0.05, Fig.9 e, n=6), whereas treatment with ValS (p<0.05) and SC19220 (p<0.05) significantly reduced the time spent in the chamber containing a familiar rat. Bonferroni’s post hoc test clearly depict that (Fig. 9 f) contact behavior of test rat with novel stimuli was significantly reduced (F 3, 40 = 6.498, p<0.05) after 7HH exposure and treatment with ValS and SC19220 increased it (not significantly). Contact behavior with familiar was increased in rats exposed to HH for 7 days, which was reduced after treatment with both inhibitors, although not significant. Time spent in the open arm of EPM was significantly lower in 7HH (One-way ANOVA, F 3, 20 = 7.508, p<0.01) exposed group and increased after administration of ValS (p<0.05) and SC19220 (p<0.05, Fig. 9 g) during 7HH exposure.
Interpretation can be drawn from these results that COX-1/EP1 axis is evident during HH exposure right from 1 day. COX-1 inhibition reduced the expression of EP1 R indicate it to be the active downstream receptor and their strong correlation strengthen this. We could also found that 7HH induced alteration in social behavior in rats was reproducibly mitigated after COX-1 inhibitor (ValS), and EP1 antagonist (SC19220) probably by reducing anxiety like behavior.
Administration of COX-1 inhibitor and EP1R antagonist differentially rescued HH induced alteration in expression of BDNF, Serotonin and pCREB.
Beneficial effect of ValS and SC19220 on social interaction as well on anxiety like behaviour and alteration in levels of BDNF, Serotonin and pCREB during HH lead to this experiment. We tested the effects of ValS and SC19220 on neurotrophic factor like BDNF and we found significant up-regulation in the expression of BDNF after COX-1 inhibition (F 3, 12 = 8.613, p<0.05, Fig. 10 a) during 7HH exposure as compare to only 7HH group. EP1R antagonism also increased BDNF expression as compare to 7HH but the elevation was not significant. On the other hand Serotonin (F 3, 20 = 2.243, Fig. 10 b) levels did not significantly increase in the hippocampus after both the treatments during 7HH. Number on pCREB positive nuclei which was drastically reduced after 7HH (p<0.001) exposure significantly rescued after administration of ValS (F 3, 20 = 10.43,p<0.01, n=3, Fig. 10 c) and SC19220(p<0.01) during 7HH.
Taken together, results showed that the inhibition of COX-1 and antagonist of EP1R rescued the perturbation of hippocampal microenvironment at some extent by elevating the expression BDNF and pCREB in DG but levels of serotonin in the hippocampus remained unchanged.
Inhibition of COX-1 as well EP1R pathway during HH stress boosts neuronal cell proliferation in DG
To test the hypothesis that the ameliorative behavioural effects of COX-1 inhibitor (ValS), and EP1 antagonist (SC19220) could be associated with adult hippocampal neurogenesis, we further tested their efficacy on HH induced deficits of neuronal proliferation in DG. Representative photomicrographs of progenitor cell marker BrdU and Ki-67 as well as DCX labelled neurons among groups are displayed (Fig. 11 a and b). Quantitative analysis of the number of BrdU labeled cells represents that 7HH exposure (One-way ANOVA, F 3, 20 = 8.876, p<0.01, Fig. 11 c) severely reduced their number in DG, treatment with ValS (p<0.05) and SC19220 (p<0.01) elevated their number. Similarly, Ki-67 labeled cells were also decreased after 7HH exposure (p<0.05), but successfully increased after treatment with ValS (F 3, 20 = 4.327, p<0.05) and SC19220 (p<0.05) during 7HH exposure indicating increase in proliferative cells in DG upon treatment. DCX labeled neurons at the proliferative stage were significantly reduced at 7HH exposure (p<0.001), increased after treatment with ValS (F 3, 20 = 10.50, p<0.05) and SC19220 (p<0.01, Fig. 11 d) significantly. Similarly, DCX labeled cells at the post-mitotic stage were also dramatically reduced (F 3, 20 = 14.54, p<0.001) upon 7HH exposure, this reduction was mitigated after treatment with ValS (not significant) as well with SC19220 (p<0.01) indicating rescue of immature neuron at proliferative and post-mitotic stage but not at intermediate stage.
Representative immunomicrograph indicating higher number of co-labelled cells (BrdU+DCX+) (NeuN+DCX+) in DG after treatment with ValS and SC-19220 (Fig. 11 e) reflecting amelioration of maturation deficits caused during 7HH stress. No difference in (BrdU+NeuN+) as well (BrdU+ GFAP+). Although, BrdU+SOX2+ cells were decreased after 7HH exposure (p<0.01) and significantly rescued after injection of ValS (One-way ANOVA, F 3, 20 = 9.676, p<0.05) and SC19220 (p<0.01, Fig. 11 f) to the rats during 7HH indicating increasing in new-born neurons in DG. 7HH exposure (p<0.001) dramatically decreased (BrdU+ DCX+) cells in DG but when ValS (F 3, 20 = 8.466, p<0.05) and SC19220 (p<0.05) were administered during HH exposure it significantly increased their number. Similarly, DCX+ NeuN+ cells were markedly reduced after 7HH exposure (p<0.001) which was significantly mitigated after ValS (F 3, 20 = 7.791, p<0.05) and SC19220 (p<0.05, Fig. 11 g) treatment clearly indicate a rescue of surviving neurons in DG. Administration of ValS and SC19220 during HH mitigated the changes in mRNA expression of genes that contribute to different functional class associated with neurogenesis with differential efficacy. Details of their expression are represented as line graphs.
The cumulative result shown here clearly indicate that treatment with ValS and SC19220 ameliorated neurogenesis deficits procreated by 7HH exposure by rescuing NPCs, new-born neurons, immature neurons and their survival in DG. Elevation of expression of BDNF and pCREB after COX-1 inhibitor and EP1R antagonist during HH exposure might be helping in rescue of adult born neurons in DG. Thus providing experimental evidence of critical role COX-1/EP1 axis in regulating BDNF dependent adult neurogenesis during HH condition.
Pharmacological inhibition of COX-1 and EP1R during 7 days of HH exposure reverts glial activation in DG
Activation of COX-1 as well EP1R promoted neuro-inflammation as well as microglia mediated neurotoxicity, we also reported COX-1 dominance in microglia in HH condition. EP1 gene ablation or selective antagonist shown to blunt microglial mediated inflammatory response. We planned our next experiment to answer the question about how COX-1/EP1R antagonism during HH can modulate morphology of microglia and astrocytes as they are prominent contributor to neurogenic niche. Representative immune-micrographs of Iba-1 and GFAP staining in DG among different groups (Fig. 12 a and b). Sholl analysis revealed different parameters like Critical value (F 3, 16 = 5.928, p<0.05), maximum branch length (F 3, 16 = 10.61, p<0.01), number of primary branches from soma (F 3, 16 = 13.2, p<0.0001), microglia process maximum (F 3, 16 = 10.61, p<0.001), decreased after 7HH exposure in DG clearly indicate activation of microglia during this stress.
Administration of ValS and SC19220 during 7HH exposure significantly ameliorated alteration in Critical value (p<0.05), maximum branch length (p<0.01), number of primary branches from soma (p<0.01, p<0.0001), microglia process maximum (p<0.05, p<0.01) indicate their ameliorative effects on microglial activation. Other parameters like Shoenen ramification index (F 3, 16 = 6.066, p<0.01), microglial soma area (F 3, 16 = 8.276, p<0.01), and number of branch endpoints (F 3, 16 = 10.76, p<0.001), were also dramatically altered after 7HH exposure. Pharmacological intervention with ValS and SC19220 during 7HH exposure also rescued parameters like Shoenen ramification index (p<0.05, p<0.05), microglial soma area (p<0.05, p<0.01), and number of branch endpoints (p<0.05, p<0.001, Fig. 12 c) respectively. This indicates that ValS and SC19220 blunted microglial activation during 7HH.
We also checked the astrocyte intensity via GFAP staining in DG where exposure to HH for 7days (F 3, 20 = 6.612, p<0.01) significantly elevated the mean intensity of GFAP in DG, this was significantly mitigated after treatment with ValS (p<0.05) and SC19220 (p<0.05). Similarly, Number of resting astrocytes in DG was also reduced after 7HH exposure (F 3, 20 = 7.368, p<0.01) but ValS and SC19220 was not able to increase them significantly. The number of activated astrocyte were also increased considerably after 7HH exposure (F 3, 20 = 6.612, p<0.01) in DG, administration of ValS (p<0.01) and SC19220 (p<0.01, Fig. 12 d) reverted their activation significantly.
Taken together, we can conclude that ValS and SC-19220 effectively rescue activation of microglia and astrocyte followed by amelioration of neuroinflammatory response. This may lead to the conclusion that COX-1 inhibition as well EP1R antagonist protecting the perturbed neurogenic niche via blunting the activation of glial cells as both COX-1 and EP1 R expression was evident in both cells specially microglia.
HH induced NLRP3/NFkB mediated neuroinflammation was reverted by specific COX-1 and EP1R inhibition
HH exposure upsurge the expression of NLRP3/NFkB pathway and pro-inflammatory cytokines in the DG and COX-1, EP1R established to increase during inflammatory stimuli, so we next investigated the ability of COX-1 inhibitor and EP1R antagonist to blunt neuroinflammation during HH condition. We found elevation in the phosphorylation of NFkB at subunit 536 at 7HH (F 3, 12 = 6.021,p<0.01, n=3) exposure which was significantly reduced after administration of ValS (p<0.05) and SC19220 (p<0.05, Fig. 13 a). NLRP3 expression was drastically up surged in the DG at 7HH exposure (F 3, 12 = 7.560, p<0.01, Fig. 13 b) which was significantly reduced upon administration of COX-1 inhibitor (p<0.05) and EP1R antagonist (p<0.05) for 7days during HH exposure. Pro-inflammatory cytokine like IL-1β (F 3, 12 = 9.694, p<0.01, Fig. 13 c), IL-6 (F 3, 12 = 11.09, p<0.01, Fig. 13 d) and TNF-α (F 3, 12 = 7.497, p<0.01 Fig. 13 e) elevated after 7HH exposure which was significantly ameliorated after treatment with ValS (p<0.01) and SC-19220 (p<0.01) in DG.
These results indicate that HH induced neuroinflammation was mediated by NLRP3/NFkB pathways which was mitigated after treatment with COX-1 inhibitor and EP1R antagonist. Reduction of pro-inflammatory cytokine was visible when COX-1 and EP1R elevation blunted after treatment with both pharmacological agents.